Clear cell odontogenic carcinoma: a diagnostic and therapeutic dilemma
© Avninder et al; licensee BioMed Central Ltd. 2006
Received: 07 June 2006
Accepted: 12 December 2006
Published: 12 December 2006
Clear cell odontogenic carcinoma is a rare odontogenic tumor occurring in the anterior region of the mandible in 5th–7th decades and shows a female preponderance. It is potentially aggressive, capable of frequent recurrences and loco-regional and distant metastases.
A 45- year- old woman presented with a radiolucent left mandibular swelling associated with loss of teeth. Left cervical lymph nodes were enlarged on palpation. The patient underwent resection of the tumor but consequent to resected margins being positive for tumor cells underwent left hemimandibulectomy with ipsilateral functional neck dissection and was free of recurrence at 8 months follow-up.
Clear cell odontogenic carcinoma should be considered in the differential diagnosis of jaw tumors with conspicuous clear cell component. Curettage or conservative resection inevitably results in recurrences and/or metastasis and more radical resection is warranted in these tumors, especially when they are large and show soft tissue invasion.
Clear cell odontogenic carcinoma (CCOC) is a rare odontogenic tumor arising from the anterior region of mandible and has a predilection for females with 43 cases reported in literature. We report a case of CCOC in the mandible of a 45- year- old female with lymph node metastasis
The patient was referred to a specialty cancer hospital where she underwent left hemimandibulectomy with ipsilateral functional neck dissection (level1 to level 5). The reconstruction was done using ipsilateral 12th rib and the soft tissue coverage was given by pectoralis major flap. Postoperative histopathological examination showed tumor morphology similar to incisional biopsy and 1/11 lymph nodes (submaxillary) was positive for the tumor metastasis without any extranodal spread. The tumor was extending into the soft tissue and the left bony margin was positive for the tumor cells. Due to the positive margin, the patient was referred for adjuvant radiotherapy for which she refused to give consent. At the time of discharge the patient was accepting soft diet and the suture line on the neck and chest were healthy. Subsequent to the discharge, the patient was lost to follow-up only to reappear after 8 months and at that time had no signs of local or regional spread. Since then patient is again lost to follow-up.
In 1985, Hansen et al., reported a locally aggressive odontogenic neoplasm, and named it clear cell odontogenic tumor . This neoplasm was initially thought to be devoid of malignant potential and classified as benign . Subsequent reports of their aggressive behavior, predilection for local recurrence, evidence of pulmonary and lymph node metastases and tumor-related deaths necessitated a change in their classification and nomenclature and is now called CCOC [3–7].
The classic clinical presentation of CCOC is a painful anterior mandibular swelling in an elderly woman. There may be loosening of adjacent teeth, and a roentgenogram shows an irregular radiolucent mass, most often in a pre-molar location. Histopathologically, CCOCs may show one or more of three architectural patterns: biphasic, monophasic, and ameloblastomatous. The most common biphasic pattern of tumor growth comprises of nests of cells with clear cytoplasm admixed with cells containing eosinophilic cytoplasm. The monophasic pattern comprises only of clear cells, while the ameloblastomatous pattern resembles the growth pattern of ameloblastoma with nests of cells showing central cystic change and squamous differentiation, and peripheral nuclear palisading with reverse polarity . The differential diagnosis of jaw tumors with prominent cytoplasmic clearing includes intraosseous salivary gland tumors (epithelial-myoepithelial carcinoma, in which the clear myoepithelial cells are immunoreactive for S-100 protein, vimentin, smooth muscle actin, and calponin; mucoepidermoid carcinoma, distinguished by its triphasic architecture comprised of mucin-positive mucous cells, squamoid cells, and intermediate cells) and metastatic tumors (classic clear cell renal cell carcinoma, which can be identified by its characteristically rich vascular pattern and its immunoreactivity for cytokeratins and vimentin and lack of reactivity for S-100 protein; and amelanotic melanoma, which reacts for HMB-45, S-100 protein and other melanoma markers). Other odontogenic tumors may also show clearing of their constituent cells. Such tumors include calcifying epithelial odontogenic tumor and clear cell ameloblastoma. While the former is identified by the presence of psammomatous calcifications and amyloid deposits, the latter may be difficult to distinguish from CCOC. In fact, some authors think that clear cell ameloblastomas and CCOCs may represent a clinico-pathological continuum of a single neoplastic entity .
A recent review of literature of the 43 cases reported so far  showed that the male: female ratio was 3:1, mean age at presentation was 58 years (range 17–89 years), the average period of follow-up was 5.5 years (range 0.5–21 years), mandible was the most favored location (84%). The overall recurrence rate for these tumors was 55% and local recurrence rates were higher (80%) for curettage alone than for resection alone (43%). Lymph node metastasis on initial presentation was rare (10%) but rapidly increased in those with recurrent disease (33%). Factors such as size of the lesion, soft tissue involvement, lymph node metastasis and most importantly, the presence or absence of positive surgical margins should be considered when developing the treatment strategy.
CCOC although rare, should be considered in differential diagnosis of jaw tumors with prominent clear cell component. The limited number of reported cases precludes a definitive assessment of prognostic factors or efficacy of therapy in CCOC. Currently, treatment is aimed at achieving wide surgical resection with tumor-free margins, and loco-regional control by lymph node resection and local radiation in cases with extensive soft tissue invasion, perineural spread, lymph node metastasis with extranodal involvement or in those where tumor-free margins are not possible. A long-term follow-up is essential as these tumors may recur locally or present with late distant metastases.
Written consent was obtained from the patient for publishing her case report.
We wish to thank Dr Sharad Sharma, Rajiv Gandhi Cancer Hospital and Research Center, New Delhi for providing details of the treatment given at their center.
- Hansen LS, Eversole LR, Green TL, Powell NB: Clear cell odontogenic tumor-a new histologic variant with aggressive potential. Head Neck Surg. 1985, 8: 115-123.View ArticlePubMedGoogle Scholar
- Kramer IRH, Pindborg JJ, Shear M: WHO Histological Typing of Odontogenic Tumor. 1992, Berlin, Germany: Springer Verlag, 2View ArticleGoogle Scholar
- Li TJ, Yu SF, Gao Y, Wang EB: Clear cell odontogenic carcinoma: a clinicopathologic and immunocytochemical study of 5 cases. Arch Pathol Lab Med. 2001, 125: 1566-1571.PubMedGoogle Scholar
- Fan J, Kubota E, Imamura H, Shimokama T, Tokunaga O, Katsuki T, Watanabe T: Clear cell odontogenic carcinoma: a case report with massive invasion of neighboring organs and lymph node metastasis. Oral Surg Oral Med Oral Pathol. 1992, 74: 768-775. 10.1016/0030-4220(92)90406-G.View ArticlePubMedGoogle Scholar
- Bang G, Koppang HS, Hansen LS, Gilhuus-Moe O, Aksdal E, Persson PG, Lundgren J: Clear cell odontogenic carcinoma: report of three cases with pulmonary and lymph node meatastasis. J Oral Pathol Med. 1989, 18: 113-118. 10.1111/j.1600-0714.1989.tb00746.x.View ArticlePubMedGoogle Scholar
- Milles M, Doyle J, Mesa M, Raz S: Clear cell odontogenic carcinoma with lymph node metastasis. Oral Surg Oral Med Oral Pathol. 1993, 76: 82-89. 10.1016/0030-4220(93)90299-J.View ArticlePubMedGoogle Scholar
- Eversole LR: Malignant epithelial odontogenic tumors. Semin Diagn Pathol. 1999, 16: 317-324.PubMedGoogle Scholar
- Braunshtein E, Vered M, Taicher S, Buchner A: Clear cello dontogenic carcinoma and clear cell ameloblastoma: a single clinicopathologic entity? A new case and comparative analysis of the literature. J Oral Maxillofac Surg. 2003, 61: 1004-1010. 10.1016/S0278-2391(03)00311-2.View ArticlePubMedGoogle Scholar
- Ebert CS, Dubin MG, Hart CF, Chalian AA, Shockley WW: Clear cell odontogenic carcinoma: a comprehensive analysis of treatment strategies. Head Neck. 2005, 27: 536-542. 10.1002/hed.20181.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.